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A 8 month-old infant presented with acute onset of severe jaundice, anemia requiring transfusion and Glucose-6-
Phosphate Dehydrogenase deficiency. The infant did not take drugs, he did not consume fava beans, but fava
beans DNA was found on pumpkin he consumed the day before jaundice onset. This is the first case of hemolysis
triggered by ingestion of food cross-contaminated with fava beans.
Keywords: Glucose-6-phosphate dehydrogenase, Favism, Children, Hemolysis, PumpkinGlucose-6-Phosphate Dehydrogenase (G6PD) deficiency is
the most common human enzymatic deficiency, caused by
a mutation in the G6PD gene, localized on X-chromosome.
Subjects affected by G6PD deficiency are prone to experi-
ence hemolytic crisis following oxidative stresses, caused
by infections, administration of some drugs and ingestion
of fava beans; for that reason, the disease is also commonly
called favism [1]. Favism is fairly common in Italy; espe-
cially in Sardinia [2].
A male 8-month old infant, presented at our Emergency
Room (ER) in February 2014 for jaundice noticed for
nearly 24 hours. He was born at term, healthy, after an un-
complicated pregnancy. He was breastfed until 6 months
of age; weaning was started from 4 months of age, without
any relevant problem. Family history was unremarkable.
The days before jaundice onset he was healthy, did not
present infections or fever, did not take any drug or sup-
plement and did not consume either food containing fava
beans or legumes not previously already eaten.
At admission to ER, the child was in good condition. His
medical examination was normal except for a remarkably
yellowish skin. Blood examinations showed unconjugated
hyperbilirubinemia (total bilirubin: 10.6 mg/dL; unconju-
gated bilirubin: 10.3 mg/dL), moderate anemia (7.6 g/dL,
Ht: 23%), reduction of red cells count (2.500.000/mm3),
anisocytosis and reticulocytosis (3.7%). Routine biochemical* Correspondence: valentina.fabiano@unimi.it
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normal. A second blood examination, 12 hours later,
showed severe anemia (Hb: 5.6 g/dL, Ht 17.7%, reticulocy-
tosis 5.9%), increased lactodehydrogenase value (739 U/L),
negative direct Coombs test. A red cell transfusion was
performed and well-tolerated. Serologies for common in-
fectious pathogens (Epstein Barr Virus, Parvovirus, Cito-
megalovirus, Hepatitis A, B and C viruses, Toxoplasma,
Mycoplasma) were negative. Haemoglobin electrophoresis
was normal. Occult blood test was negative. Dosage of
G6PD showed en enzymatic deficiency (16 U/1012 RBC;
reference ranges 146–376 U/1012 RBC) and a diagnosis of
favism was made. A precise drug and food anamnesis was
made, searching for a precipitating factor for hemolysis:
the day before jaundice onset, the infant ate pumpkin for
the first time. We hypothesized that the pumpkin may
have been cross-contaminated with fava beans.Findings
A sample of frozen pumpkin (Cucurbita maxima), those
consumed by the child, was sent to the Laboratory of the
Genomics Platform - Parco Tecnologico Padano (PGP), an
Italian reference laboratory for molecular analysis in the
field of genomics applied to the agri-food sector. A three-
step analysis was performed. First, DNA was extracted from
the surface of the pumpkin sample using a commercial col-
umn kit (QIAMP Fast DNA Stool Qiagen®). Secondly, a test
for DNA amplificability (qualitative-PCR for the trnL gene
sequences in the chloroplast of the plant) showed that the
obtained DNA was perfectly amplifiable, without evidencel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Electrophoretic profile of Vicia faba microsatellite molecular marker GBSSR-VF-8.
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product showed a 100% similarity to Cucurbita maxima
trnL gene reference sequences (NCBI). Then, soybean
(Glicyne max), pea (Pisum sativum) and fava bean (Vicia
fava) DNA were searched for in the pumpkin extracted
DNA. Signal amplification of specific markers for soybean
(Lectine gene) and pea (SSR markers) were not found, on
the contrary, the amplification products of fava bean
markers were detected in the analyzed sample. To verifyFigure 2 Electrophoretic profile of Vicia faba microsatellite molecularthe presence of fava bean DNA, the PGP team analyzed
microsatellite molecular markers (SSR - simple sequence
repeat). These markers are a stretch of repeated DNA,
made up of a variable number of tandem repeats of a
limited number of nucleotides. A set of four Vicia faba spe-
cific SSR markers (GBSSR-VF-8, GBSSR-VF-19, GBSSR-
VF-20, GBSSR-VF-52) was used [3] and two (GBSSR-VF-8
and GBSSR-VF-20) of them showed amplification products
with the size expected for Vicia faba on the DNA extractedmarker GBSSR-VF-20.
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hyphotesized a case of cross-contamination between
pumpkin and fava bean. The ingestion of substances
present in the fava beans, pyrimidine, vicine and convi-
cine’s beta-glucosides, can trigger hemolytic crisis with
variably severe clinical manifestations. The combination of
some factors, such as residual enzymatic activity, the
metabolic characteristics of the individual, the general
health state or the amount of fava beans ingested, may
have a relevant role to determine the severity of the symp-
toms [1]. Most of the episodes of favism has been reported
in individuals with severe enzymatic deficiency [4]. Chil-
dren with G6PD deficiency seem to be more prone to
hemolytic crisis triggered by fava beans’ ingestion respect
to adults; this is possibly due to the relatively greater ex-
posure for the lower body surface. Fresh fava beans are
more harmful than those treated. Beta-glucosides are
more concentrated in less mature fava beans, whose inges-
tion may be correlated to more severe symptoms [5].
To our knowledge, this is the first case of severe
hemolytic crisis triggered by ingestion of a fava beans
cross-contaminated food. It underlines the importance of
considering possible cross-contamination between foods
which grow in the same fields or are treated along the
same food supply chain. In G6PD deficient subjects, whose
enzymatic residual activity is very low or in pediatric pa-
tients, cross-contamination of foods with fava beans may
possibly represent a risk factor for hemolytic crisis even if
a small quantity of contaminated food is ingested. A clear
declaration of the possible cross-contamination with fava
beans should be reported on product labels, at least for
those foods for which it is more likely to occur.
Consent
Written informed consent was obtained from the patient’s
parents for the publication of this report.
Abbreviations
ER: Emergency room; G6PD: Glucose-6Phosphate-Dehydrogenase.
Competing interest
The authors declare that they have no competing interests.
Authors’ contributions
VF, FR, CM, DD and GVZ have written the first draft of the paper, have given
final approval of the version to be published; and agree to be accountable
for all aspects of the work in ensuring that questions related to the accuracy
or integrity of any part of the work are appropriately investigated and
resolved; Valentina Gualdi and Valeria Rizzi performed DNA analysis, have
given final approval of the version to be published; and agree to be
accountable for all aspects of the work in ensuring that questions related to
the accuracy or integrity of any part of the work are appropriately
investigated and resolved. All authors read and approved the final
manuscript.
Author details
1Department of Pediatrics, Luigi Sacco Hospital, University of Milan, Via G.B.
Grassi, 74, 20157 Milan, Italy. 2Parco Tecnologico Padano, Via Einstein, Loc
Cascina Codazza, 26900 Lodi, MI, Italy.Received: 18 June 2014 Accepted: 30 June 2014
Published: 21 July 2014
References
1. Cappellini MD, Fiorelli G: Glucose-6-phosphate dehydrogenase deficiency.
Lancet 2008, 371:64–74.
2. Siniscalco M, Bernini M, Filippi G, Latte B, Meera Khan P, Piomelli S, Rattazzi
M: Population genetics of haemoglobin variants, thalassaemia and G6PD
deficiency, with particular reference to the malarial hypothesis. Bull WHO
1966, 34:379–393.
3. Suresh S, Park JH, Cho GT, Lee HS, Baek HJ, Lee SY, Chung JW:
Development and molecular characterization of 55 novel polymorphic
cDNA-SSR markers in Faba Bean (Vicia faba L.) using 454 pyrosequencing.
Molecules 2013, 18:1844–1856.
4. Beutler E: G6PD deficiency. Blood 1994, 84:3613–3636.
5. Meloni T, Forteleoni G, Dore A, Cutillo S: Favism and hemolytic anemia in
glucose-6-phosphate dehydrogenase-deficient subjects in North
Sardinia. Acta Haematol 1983, 70:83–90.
doi:10.1186/1824-7288-40-71
Cite this article as: Zuccotti et al.: Hemolytic crisis in a G6PD-deficient
infant after ingestion of pumpkin. Italian Journal of Pediatrics 2014 40:71.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
